[{"address1": "1800 Sierra Point Parkway", "address2": "Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 484 0899", "website": "https://dayonebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.", "fullTimeEmployees": 182, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Bender M.B.A., Ph.D.", "age": 53, "title": "CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1195600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles N. York II, M.B.A.", "age": 47, "title": "COO & CFO", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 854200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Dubow J.D.", "age": 57, "title": "General Counsel, Chief Compliance Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 692700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Stubenrauch Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Heather Adkins Huet Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joey  Perrone", "title": "Senior Vice President of Finance & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaa  Roberson", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Davy  Chiodin Ph.D., Pharm.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren  Merendino M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elly  Barry M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.47, "open": 7.32, "dayLow": 7.135, "dayHigh": 7.49, "regularMarketPreviousClose": 7.47, "regularMarketOpen": 7.32, "regularMarketDayLow": 7.135, "regularMarketDayHigh": 7.49, "payoutRatio": 0.0, "beta": -1.263, "forwardPE": -6.428571, "volume": 724444, "regularMarketVolume": 724444, "averageVolume": 1511470, "averageVolume10days": 1206440, "averageDailyVolume10Day": 1206440, "bid": 7.17, "ask": 7.21, "bidSize": 4, "askSize": 3, "marketCap": 737509888, "fiftyTwoWeekLow": 5.635, "fiftyTwoWeekHigh": 16.76, "allTimeHigh": 28.699, "allTimeLow": 5.44, "priceToSalesTrailing12Months": 3.930493, "fiftyDayAverage": 7.095, "twoHundredDayAverage": 8.1088, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 287409920, "profitMargins": -0.50627, "floatShares": 78723038, "sharesOutstanding": 102431933, "sharesShort": 10724894, "sharesShortPriorMonth": 11276359, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.1047, "heldPercentInsiders": 0.16936001, "heldPercentInstitutions": 0.85331, "shortRatio": 9.94, "shortPercentOfFloat": 0.155, "impliedSharesOutstanding": 102431933, "bookValue": 4.499, "priceToBook": 1.6003556, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -94995000, "trailingEps": -0.89, "forwardEps": -1.12, "enterpriseToRevenue": 1.532, "enterpriseToEbitda": -2.641, "52WeekChange": -0.5177495, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 7.2, "targetHighPrice": 34.0, "targetLowPrice": 16.0, "targetMeanPrice": 23.55556, "targetMedianPrice": 25.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 453103008, "totalCashPerShare": 4.423, "ebitda": -108806000, "totalDebt": 3003000, "quickRatio": 9.23, "currentRatio": 9.653, "totalRevenue": 187638000, "debtToEquity": 0.652, "revenuePerShare": 1.853, "returnOnAssets": -0.1519, "returnOnEquity": -0.24752001, "grossProfits": 176416992, "freeCashflow": -143568624, "operatingCashflow": -63058000, "revenueGrowth": 3.139, "grossMargins": 0.9402, "ebitdaMargins": -0.57987, "operatingMargins": -1.03144, "financialCurrency": "USD", "symbol": "DAWN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "epsTrailingTwelveMonths": -0.89, "epsForward": -1.12, "epsCurrentYear": -1.17934, "priceEpsCurrentYear": -6.105109, "fiftyDayAverageChange": 0.10500002, "fiftyDayAverageChangePercent": 0.014799157, "twoHundredDayAverageChange": -0.9088001, "twoHundredDayAverageChangePercent": -0.11207578, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622122200000, "marketState": "CLOSED", "earningsTimestamp": 1754424000, "earningsTimestampStart": 1761768000, "earningsTimestampEnd": 1761768000, "earningsCallTimestampStart": 1754425800, "earningsCallTimestampEnd": 1754425800, "isEarningsDateEstimate": true, "postMarketChangePercent": 0.555555, "postMarketPrice": 7.24, "postMarketChange": 0.04, "regularMarketChange": -0.27, "regularMarketDayRange": "7.135 - 7.49", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-27", "averageAnalystRating": "1.6 - Buy", "longName": "Day One Biopharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1760744861, "regularMarketTime": 1760731201, "exchange": "NMS", "messageBoardId": "finmb_704589075", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Day One Biopharmaceuticals, Inc", "regularMarketChangePercent": -3.61446, "regularMarketPrice": 7.2, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1511470, "fiftyTwoWeekLowChange": 1.5649996, "fiftyTwoWeekLowChangePercent": 0.2777284, "fiftyTwoWeekRange": "5.635 - 16.76", "fiftyTwoWeekHighChange": -9.56, "fiftyTwoWeekHighChangePercent": -0.5704057, "fiftyTwoWeekChangePercent": -51.77495, "displayName": "Day One Biopharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]